drugset / Trial / NCT00812045
Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of AZD1236 in patients with cystic fibrosis (CF) on inflammatory biomarkers in induced sputum, after a treatment period of 4 weeks.
Timeline
- Start
- 2009-12
- Primary completion
- —
- Completion
- 2010-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1236 | Small molecule | 75 mg | Oral |